1.Immunohistochemical Study on the Expression of c-erbB-2 Oncoprotein in the Odontogenic cysts.
Sung Woon PYO ; Chang Hyen KIM ; Won LEE ; Young Sil KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2001;27(1):32-36
To investigate epithelial cell proliferation reactivity in the odontogenic cysts, the expression of c-erbB-2 oncoprotein by epithelial lining was studied in odontogenic keratocyst(OKC, n=10), dentigerous cyst(DC, n=12), radicular cyst(RC, n=12) and normal dental follicle(n=7). The c-erbB-2 immunoreactivity was studied using a streptavidine- biotin- peroxidase method with polyclonal rabbit anti-human antibody to c-erbB-2 oncoprotein which is known to react with formalin fixed, paraffin-embedded sections and the intensity of staining was determined by manually. In all of 10(100%) OKCs, showed positive expression for c-erbB-2 oncoprotein compared with 10/12(83.3%) in DCs, 11/12(91.7%) in RCs and 5/7(71.4%) in normal dental follicles. The expression within OKC was higher than that of DC, RC and dental follicle but statistically not significant(p>0.05) and but may reflects underlying genetic defect. These results demonstrate differences in c-erbB-2 expression between the epithelial linings of the three major odontogenic cyst types, indicating differences in proliferation activity and differentiation processes within these lesions. And, in particular, these results are able to explain the peculiar aggressive growth pattern of OKC.
Dental Sac
;
Epithelial Cells
;
Formaldehyde
;
Immunohistochemistry
;
Odontogenic Cysts*
;
Peroxidase
2.MR imaging of intramedullary tumors of the spinal cord: comparison with surgical findings.
Du Whan CHOE ; Hee Young HWANG ; Hyeon Kyeong LEE ; Moon Hee HAN ; In One KIM ; Hyen Jip KIM ; Kee Hyung CHANG
Journal of the Korean Radiological Society 1991;27(5):626-631
No abstract available.
Magnetic Resonance Imaging*
;
Spinal Cord*
3.Clinical analysis of open heart surgery: review of 477 cases.
Pil Soo LEE ; Han Yong KIM ; Jae Hyen CHANG ; Jae Ho CHO ; Won Young SONG ; Byung Ha YOON
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(7):741-750
No abstract available.
Heart*
;
Thoracic Surgery*
4.Induction of apoptosis in oral cancer cell line through an recombinant HCCS-1 adenovirus.
Chang Hyen KIM ; Dong Ju LEE ; ll Kyu LEE ; Myung Jin KIM ; Jin Woo KIM ; Sung Woon PYO
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2005;31(4):306-311
Despite advances in surgery, radiotherapy, and chemotherapy, the survival of patients with oral squamous cell carcinoma has not significantly improved over the past several decades. Gene therapy is currently under investigation and shows us new possibility of cancer curing method. This experiment was undergone to find out the cell growth inhibition effect and evidence of apoptosis by HCCS-1(human cervical cancer suppressor-1), one of the candidates of tumor suppressor gene, transducted to human oral cancer cell line. To determine the efficiency of the adenovirus as a gene delivery vector cell line was transducted with LacZ gene and analysed with X-gal staining. Northern blot was performed to confirm the transfection with HSCC-1 gene and cell viability was assessed by cell cytotoxicity assay using cell count kit(CCK). To show the evidence of apoptosis, DNA fragmentation assay and flow cytometry(FACS) were performed. We had successfully construct the recombinant HSCC-1 adenovirus(Ad5CMV-HCCS-1), and importation efficiency was 20% at 2 MOI(multiplicity of infection), 80% at 20 MOI. Northern blot analysis showed that a single 0.6kb mRNA transcript was expressed in Ad5CMV-HCCS-1 transducted cell lines. As a result of CCK, when comparing to control subjects, transducted group showed 50% growth inhibition. In DNA fragmentation assay, according to increasing of MOI, DNA volume was diminished. In FACS analysis, DNA distribution showed fragmentation.This results imply that HCCS-1gene has growth inhibition effect in human oral cancer cell lines through apoptosis induction.
Adenoviridae*
;
Apoptosis*
;
Blotting, Northern
;
Carcinoma, Squamous Cell
;
Cell Count
;
Cell Line*
;
Cell Survival
;
DNA
;
DNA Fragmentation
;
Drug Therapy
;
Genes, Tumor Suppressor
;
Genes, vif
;
Genetic Therapy
;
Humans
;
Lac Operon
;
Mouth Neoplasms*
;
Radiotherapy
;
RNA, Messenger
;
Transfection
;
Uterine Cervical Neoplasms
5.Bone Cement-Augmented Short Segment Fixation with Percutaneous Screws for Thoracolumbar Burst Fractures Accompanied by Severe Osteoporosis.
Hyun Jin JUNG ; Seok Won KIM ; Chang Il JU ; Sung Hoon KIM ; Hyen Sung KIM
Journal of Korean Neurosurgical Society 2012;52(4):353-358
OBJECTIVE: The purpose of this study was to determine the efficacy of bone cement-augmented short segment fixation using percutaneous screws for thoracolumbar burst fractures in a background of severe osteoporosis. METHODS: Sixteen patients with a single-level thoracolumbar burst fracture (T11-L2) accompanying severe osteoporosis treated from January 2008 to November 2009 were prospectively analyzed. Surgical procedures included postural reduction for 3 days and bone cement augmented percutaneous screw fixation at the fracture level and at adjacent levels without bone fusion. Due to the possibility of implant failure, patients underwent implant removal 12 months after screw fixation. Imaging and clinical findings, including involved vertebral levels, local kyphosis, canal encroachment, and complications were analyzed. RESULTS: Prior to surgery, mean pain score (visual analogue scale) was 8.2 and this decreased to a mean of 2.2 at 12 months after screw fixation. None of the patients complained of pain worsening during the 6 months following implant removal. The percentage of canal compromise at the fractured level improved from a mean of 41.0% to 18.4% at 12 months after surgery. Mean kyphotic angle was improved significantly from 19.8degrees before surgery to 7.8 at 12 months after screw fixation. Canal compromise and kyphotic angle improvements were maintained at 6 months after implant removal. No significant neurological deterioration or complications occurred after screw removal in any patient. CONCLUSION: Bone cement augmented short segment fixation using a percutaneous system can be an alternative to the traditional open technique for the management of selected thoracolumbar burst fractures accompanied by severe osteoporosis.
Humans
;
Kyphosis
;
Osteoporosis
;
Prospective Studies
6.Current review of molecular biology in distraction osteogenesis.
Yu Jin JEE ; Hyun Chul SONG ; Yeo Gab KIM ; Jin KIM ; Chang Hyen KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2002;28(6):456-463
Distraction osteogenesis is a well-established clinical treatment for limb length discrepancy and skeletal deformities. Appropriate mechanical tension-stress is believed not to break the callus but rather to stimulate osteogenesis. In contrast to fracture healing, the mode of bone formation in distraction osteogenesis is primarily intramembranous ossification. Although the biomechanical, histological, and ultrastructural changes associated with distraction osteogenesis have been widely described, the basic biology of the process is still not well known. Moreover, the molecular mechanisms in distraction osteogenesis remain largely unclear. Recent studies have implicated the growth factor cascade is likely to play an important role in distraction. And current reserch suggested that mechanical tension-stress modulates cell shape and phenotype, and stimulates the expression of the mRNA for bone matrix proteins. This article presents the hypotheses and current research that have furthered knowledge of the molecular biology that govern distraction osteogenesis. The gene regulation of growth factors and extracellular matrix proteins during distraction osteogenesis are discussed in this article. It is believed that understanding the biomolecular mechanisms that mediate distraction osteogenesis may guide the development of targeted strategies designed to improve distraction osteogenesis and accelerate bone healing.
Biology
;
Bone Matrix
;
Bony Callus
;
Cell Shape
;
Congenital Abnormalities
;
Extracellular Matrix Proteins
;
Extremities
;
Fracture Healing
;
Intercellular Signaling Peptides and Proteins
;
Molecular Biology*
;
Osteogenesis
;
Osteogenesis, Distraction*
;
Phenotype
;
RNA, Messenger
8.A clinical evaluation of safety of an office bleaching gel containing 30% hydrogen peroxide.
Sin Young KIM ; Je Uk PARK ; Chang Hyen KIM ; Sung Eun YANG
Journal of Korean Academy of Conservative Dentistry 2010;35(3):198-210
This study evaluated the safety of an office bleaching gel (RemeWhite, Remedent Inc., Deurle, Belgium) containing 30% hydrogen peroxide. 37 volunteers were recieved office bleaching with the RemeWhite for 3 times at one visit, total 2 visits. As control group, the same gel in which hydrogen peroxide was not included was applied to 34 volunteers with the same protocol. There was no difference between experimental group and control group using electric pulp test. In the result of gingival inflammation index and tooth sensitivity test, there was mild pain response in experimental group but it disappeared as time went by. Therefore, safety of the office bleaching gel containing 30% hydrogen peroxide was confirmed.
Hydrogen
;
Hydrogen Peroxide
;
Inflammation
;
Tooth
9.Expression of e-cadherin with correlation to clinicopathologic parameters in oral squamous cell carcinoma.
Jae Myoung SHIN ; Young Sill KIM ; Chang Hyen KIM ; Sung Woon PYO
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2005;31(1):1-6
It becomes more concerned that the cell adhesion molecule plays an important role in the process of malignant transformation and tumor behaviors including invasive growth and metastasis. It is postulated if the expression of adhesion molecule is reduced in tumor tissue, the tumor cell will be undifferentiated and lose their cell adhesion ability and polarity. So the tumor cells lost the adhesion of cell to cell and to basement membrane that they became more aggressive. Reduced cadherin expression enhances invasiveness through infiltrative growth and metastasis of tumor cells is well known and mostly accepted in many epithelia tumors. We explored the expression of E-cadherin by immunohistochemical staining in 50 oral squamous cell carcinomas and investigated the correlation between the expression of E-cadherin and clinicopathologic parameters and prognosis. The expression of E-cadherin was reduced in 40/50(80%) of primary tumors, and 21/22(95.5%) of lymph nodes. The reduced expression of the E-cadherin was associated with lymph node metastasis(P=0.029), invasive mode(P=0.030) and marginal status(P=0.038). Survival analysis showed that predictive period of E-cadherin reduced group(37 months) was lower than that of E-cadherin preserved group(60 months), but there was no statistical significant difference.
Basement Membrane
;
Cadherins*
;
Carcinoma, Squamous Cell*
;
Cell Adhesion
;
Lymph Nodes
;
Neoplasm Metastasis
;
Prognosis
10.The hypermethylation of E-cadherin gene in oral squamous cell carcinoma.
Sung Woon PYO ; Young Sill KIM ; Ji Young PARK ; Chang Hyen KIM ; Won LEE ; Min Kyu PARK
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2008;34(2):135-140
Loss of E-cadherin (E-cad) expression has been found in multiple cancers and is postulated to facilitate tumor cell dissociation and metastais. Promotor methylation may provides an alternative pathway for loss of gene function. This study evaluated the role of hypermethylation in the down-regulation of E-cad in oral squamous cell carcinoma (OSCC). We examined the E-cad expression by immunohistochemical staining and detected methylation status by methylation-specific polymerase chain reaction (MSP) in 20 OSCC tissues. Overally, 12 (60 %) cases of hypermethylation of E-cad were detected and we found there were no correlation between methylation and age, histologic grade, lympn node metastasis, tumor size and clinical stage. However, Eleven (73.3 %) of 15 samples which was negative for E-cad staining showed hypermethylation of E-cad promotor region. On the other hand, only one (20 %) of 5 E-cad positive sample was observed with methylated status. The underexpression of E-cad was found to be related to promotor hypermethylation (p=0.035). In conclusion, we suggest that hypermethylation play a role in inactivation of E-cad gene and may be a appreciable biomarker for diagnosis and treatment of OSCC.
Cadherins
;
Carcinoma, Squamous Cell
;
Dissociative Disorders
;
Down-Regulation
;
Hand
;
Methylation
;
Neoplasm Metastasis
;
Polymerase Chain Reaction
;
Promoter Regions, Genetic